GSK to cut 1,217 jobs in Wallonia, pivots to oncology from vaccines
Published 2 d ago1 sourceEvidence: Reported
Orexo reported a Q3 2026 net loss of SEK 96.4 million, up from SEK 29.8 million a year earlier, driven by restructuring costs and a settlement with the DOJ. The loss per share widened to SEK 3.36 from SEK 2.87. The settlement resolves a legal overhang but the restructuring signals ongoing operational challenges.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 2 d ago1 sourceEvidence: Reported
Published 10 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 8 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 21 h ago8 sourcesEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported
Published 6 h ago2 sourcesEvidence: Reported